CareDx Return on Tangible Equity 2013-2025 | CDNA
Current and historical return on tangible equity values for CareDx (CDNA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| CareDx Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.06B | $0.30B | 25.79% |
| 2024-12-31 | $0.05B | $0.30B | 25.00% |
| 2024-09-30 | $-0.15B | $0.19B | -80.77% |
| 2024-06-30 | $-0.16B | $0.18B | -77.42% |
| 2024-03-31 | $-0.19B | $0.17B | -76.15% |
| 2023-12-31 | $-0.19B | $0.18B | -66.73% |
| 2023-09-30 | $-0.09B | $0.31B | -27.40% |
| 2023-06-30 | $-0.08B | $0.32B | -24.67% |
| 2023-03-31 | $-0.08B | $0.34B | -23.14% |
| 2022-12-31 | $-0.08B | $0.35B | -21.43% |
| 2022-09-30 | $-0.08B | $0.36B | -20.46% |
| 2022-06-30 | $-0.07B | $0.36B | -18.56% |
| 2022-03-31 | $-0.05B | $0.37B | -12.87% |
| 2021-12-31 | $-0.03B | $0.38B | -7.84% |
| 2021-09-30 | $-0.02B | $0.40B | -5.38% |
| 2021-06-30 | $-0.01B | $0.41B | -3.29% |
| 2021-03-31 | $-0.02B | $0.40B | -5.98% |
| 2020-12-31 | $-0.02B | $0.21B | -12.56% |
| 2020-09-30 | $-0.02B | $0.20B | -18.34% |
| 2020-06-30 | $-0.02B | $0.19B | -28.07% |
| 2020-03-31 | $-0.02B | $0.03B | -71.79% |
| 2019-12-31 | $-0.02B | $0.03B | -68.15% |
| 2019-09-30 | $-0.02B | $0.03B | -56.41% |
| 2019-06-30 | $-0.04B | $0.03B | -100.00% |
| 2019-03-31 | $-0.05B | $0.05B | -157.26% |
| 2018-12-31 | $-0.05B | $0.05B | -348.15% |
| 2018-09-30 | $-0.08B | $0.03B | 625.00% |
| 2018-06-30 | $-0.07B | $-0.02B | 219.05% |
| 2018-03-31 | $-0.06B | $-0.01B | 166.20% |
| 2017-12-31 | $-0.06B | $-0.05B | 139.13% |
| 2017-09-30 | $-0.04B | $-0.05B | 113.87% |
| 2017-06-30 | $-0.03B | $-0.03B | 98.31% |
| 2017-03-31 | $-0.04B | $-0.03B | 120.69% |
| 2016-12-31 | $-0.04B | $-0.03B | 185.71% |
| 2016-09-30 | $-0.03B | $-0.03B | 252.17% |
| 2016-06-30 | $-0.03B | $-0.03B | 2800.00% |
| 2016-03-31 | $-0.02B | $0.00B | -182.61% |
| 2015-12-31 | $-0.01B | $0.01B | -80.00% |
| 2015-09-30 | $-0.01B | $0.02B | -41.56% |
| 2015-06-30 | $0.00B | $0.02B | -19.05% |
| 2015-03-31 | $0.00B | $0.02B | 0.00% |
| 2014-12-31 | $0.00B | $0.02B | 50.00% |
| 2014-09-30 | $0.00B | $0.02B | 0.00% |
| 2014-06-30 | $0.00B | $-0.02B | 15.38% |
| 2014-03-31 | $0.00B | $-0.02B | 50.00% |
| 2013-12-31 | $0.00B | $-0.02B | 106.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.087B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.286B | 26.31 |
| Elevance Health (ELV) | United States | $88.874B | 11.47 |
| CVS Health (CVS) | United States | $80.430B | 10.00 |
| Cencora (COR) | United States | $56.003B | 19.48 |
| DiDi Global (DIDIY) | China | $23.532B | 35.71 |
| Natera (NTRA) | United States | $22.361B | 0.00 |
| BioMerieux (BMXMF) | France | $16.097B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.999B | 0.00 |
| Solventum (SOLV) | United States | $12.948B | 13.71 |
| CochLear (CHEOY) | Australia | $11.388B | 0.00 |
| ICON (ICLR) | Ireland | $11.234B | 10.44 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Revvity (RVTY) | United States | $10.840B | 18.66 |
| Viatris (VTRS) | United States | $10.223B | 3.51 |
| HealthEquity (HQY) | United States | $9.646B | 42.25 |
| Avantor (AVTR) | United States | $8.906B | 12.94 |
| Medpace Holdings (MEDP) | United States | $8.522B | 22.63 |
| Sonic Healthcare (SKHHY) | Australia | $8.301B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.107B | 13.93 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.201B | 38.89 |
| Bausch + Lomb (BLCO) | Canada | $4.139B | 24.38 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Alignment Healthcare (ALHC) | United States | $3.011B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.972B | 38.65 |
| Concentras Parent (CON) | United States | $2.824B | 16.32 |
| Organon (OGN) | United States | $2.485B | 2.64 |
| Ardent Health Partners (ARDT) | United States | $2.126B | 9.06 |
| GeneDx Holdings (WGS) | United States | $2.056B | 79.20 |
| Premier (PINC) | United States | $1.889B | 14.33 |
| Progyny (PGNY) | United States | $1.858B | 40.91 |
| PACS (PACS) | United States | $1.591B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.457B | 29.14 |
| Teladoc Health (TDOC) | United States | $1.275B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.210B | 9.21 |
| Establishment Labs Holdings (ESTA) | $1.099B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.894B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.808B | 7.56 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.678B | 10.26 |
| LifeMD (LFMD) | United States | $0.578B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| Enhabit (EHAB) | United States | $0.547B | 45.00 |
| InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| Sonida Senior Living (SNDA) | United States | $0.478B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.449B | 0.00 |
| Oncology Institute (TOI) | United States | $0.248B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.244B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.096B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.089B | 0.00 |
| OncoCyte (OCX) | United States | $0.085B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.073B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.058B | 0.00 |
| ModivCare (MODV) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |